{"altmetric_id": 86279956, "counts": {"readers": {"citeulike": "0", "mendeley": "11", "connotea": "0"}, "total": {"posts_count": 75}, "twitter": {"unique_users_count": 63, "posts_count": 70}, "news": {"unique_users_count": 5, "unique_users": ["sciencenewsnet_in", "scienmag", "newswise", "eurekalert", "the_medical_news"], "posts_count": 5}}, "citation": {"altmetric_jid": "532721422a83ee84788b4567", "authors": ["Ye, Chengjin", "Chiem, Kevin", "Park, Jun-Gyu", "Oladunni, Fatai", "Platt, Roy Neal", "Anderson, Tim", "Almazan, Fernando", "de la Torre, Juan Carlos", "Martinez-Sobrido, Luis"], "doi": "10.1101/2020.07.22.216358", "first_seen_on": "2020-07-23T03:04:33+00:00", "issns": [], "journal": "bioRxiv", "last_mentioned_on": 1621068317, "links": ["https://www.biorxiv.org/content/10.1101/2020.07.22.216358v1", "https://www.biorxiv.org/content/10.1101/2020.07.22.216358v1.full"], "pdf_url": "https://www.biorxiv.org/content/biorxiv/early/2020/07/22/2020.07.22.216358.full.pdf", "pmid": "32743573", "publisher": "Cold Spring Harbor Laboratory", "title": "Rescue of SARS-CoV-2 from a single bacterial artificial chromosome", "type": "article", "mendeley_url": "https://www.mendeley.com/catalogue/2b2b459b-c206-36e3-91a1-773fce996ff6/"}, "altmetric_score": {"score": 82.35, "score_history": {"1y": 82.35, "6m": 0.25, "3m": 0.25, "1m": 0.25, "1w": 0.25, "6d": 0.25, "5d": 0.25, "4d": 0, "3d": 0, "2d": 0, "1d": 0, "at": 82.35}, "context_for_score": {"all": {"total_number_of_other_articles": 17759439, "mean": 9.45271436671, "rank": 311795, "this_scored_higher_than_pct": 98, "this_scored_higher_than": 17450162, "rank_type": "exact", "sample_size": 17759439, "percentile": 98}, "similar_age_3m": {"total_number_of_other_articles": 301614, "mean": 18.479177863096, "rank": 11058, "this_scored_higher_than_pct": 96, "this_scored_higher_than": 290573, "rank_type": "exact", "sample_size": 301614, "percentile": 96}, "this_journal": {"total_number_of_other_articles": 121674, "mean": 13.893120009205, "rank": 2193, "this_scored_higher_than_pct": 98, "this_scored_higher_than": 119483, "rank_type": "exact", "sample_size": 121674, "percentile": 98}, "similar_age_this_journal_3m": {"total_number_of_other_articles": 9169, "mean": 14.581512051478, "rank": 211, "this_scored_higher_than_pct": 97, "this_scored_higher_than": 8958, "rank_type": "exact", "sample_size": 9169, "percentile": 97}}}, "demographics": {"poster_types": {"member_of_the_public": 59, "researcher": 1, "practitioner": 3}, "users": {"twitter": {"cohorts": {"Members of the public": 59, "Scientists": 1, "Practitioners (doctors, other healthcare professionals)": 3}}, "mendeley": {"by_status": {"Researcher": 2, "Student  > Master": 1, "Student  > Ph. D. Student": 1, "Student  > Bachelor": 2, "Student  > Doctoral Student": 1, "Other": 1, "Librarian": 3}, "by_discipline": {"Medicine and Dentistry": 5, "Psychology": 1, "Nursing and Health Professions": 2, "Biochemistry, Genetics and Molecular Biology": 1, "Arts and Humanities": 1, "Veterinary Science and Veterinary Medicine": 1}}}, "geo": {"twitter": {"US": 3, "FI": 1, "JP": 1, "MX": 1, "ES": 20, "EC": 1, "BE": 1}}}, "posts": {"twitter": [{"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "1949132852"}, "tweet_id": "1286135022966185986"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "748908558066982916"}, "tweet_id": "1286135023779840001"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "28358443"}, "tweet_id": "1286135046294786049"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "91557842"}, "tweet_id": "1286141801527640065"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "977034655538049025"}, "tweet_id": "1286147958627602432"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "125919040"}, "tweet_id": "1286187507462238208"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1286263591344185346"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1286263613007826945"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1286264155050250240"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "1257401497052000256"}, "tweet_id": "1286707159556698112"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "1265336030833422337"}, "tweet_id": "1286858235199119360"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "291297961"}, "tweet_id": "1287047848727543809"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "276090406"}, "tweet_id": "1287048282942902272"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "4765330759"}, "tweet_id": "1287048550535307264"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "89729806"}, "tweet_id": "1287048810418626562"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "51694639"}, "tweet_id": "1287049289211039745"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "1223247528642195457"}, "tweet_id": "1287049456635064320"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "1046809881171382273"}, "tweet_id": "1287049618249965568"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "257501141"}, "tweet_id": "1287051717134163968"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "579244077"}, "tweet_id": "1287052609489182731"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "326724877"}, "tweet_id": "1287053685843996674"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "726596287"}, "tweet_id": "1287053818442776578"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "1262764059926990850"}, "tweet_id": "1287054789487005698"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "397198724"}, "tweet_id": "1287055036422463488"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "1183732091097403392"}, "tweet_id": "1287057249001771009"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "766191187"}, "tweet_id": "1287060704877568001"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "535747968"}, "tweet_id": "1287062837731434496"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "2364907057"}, "tweet_id": "1287063717990084608"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "768006384868790272"}, "tweet_id": "1287064245272707074"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "355453703"}, "tweet_id": "1287064552572694528"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "834113389"}, "tweet_id": "1287065337599533058"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "2664830020"}, "tweet_id": "1287065958406856706"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "1152342368416387073"}, "tweet_id": "1287066349370515457"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "2499691624"}, "tweet_id": "1287072219563208707"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "1236355054959038464"}, "tweet_id": "1287075847757860864"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "1242742609178767360"}, "tweet_id": "1287079825652547585"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "461601654"}, "tweet_id": "1287084670568587269"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "3310939763"}, "tweet_id": "1287087010818162688"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "3081233963"}, "tweet_id": "1287089027464810496"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "1220731426280263680"}, "tweet_id": "1287098420885426176"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "846507694093717509"}, "tweet_id": "1287101811929812992"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "474267094"}, "tweet_id": "1287119384499167232"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "984872346"}, "tweet_id": "1287127542965600257"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "312240806"}, "tweet_id": "1287130320412778501"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "1082714530512281605"}, "tweet_id": "1287130553104375808"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "1242209084478234625"}, "tweet_id": "1287133197508247553"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "18323565"}, "tweet_id": "1287139229613654016"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "2692076577"}, "tweet_id": "1287151818590560256"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "892120710667264001"}, "tweet_id": "1287160187338588167"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "392596816"}, "tweet_id": "1287160331513536512"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "1242783418280280070"}, "tweet_id": "1287165216132923393"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "1211006786863431680"}, "tweet_id": "1287174370566299649"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "153072980"}, "tweet_id": "1287175459017568260"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "1262643206933688321"}, "tweet_id": "1287219896762413056"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "731803004152774657"}, "tweet_id": "1287272328494297089"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "439430918"}, "tweet_id": "1287295337795850240"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "1033066053994246146"}, "tweet_id": "1287299328592302080"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "940071510"}, "tweet_id": "1287306736571949056"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "940071510"}, "tweet_id": "1287307862386106368"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "1641711331"}, "tweet_id": "1287324527106629632"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "1255070546481602560"}, "tweet_id": "1287387652002586627"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "309045510"}, "tweet_id": "1287488676361048064"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "1247296335021322241"}, "tweet_id": "1287530996569710592"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "1262643206933688321"}, "tweet_id": "1288105307365945346"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "1288600383426830336"}, "tweet_id": "1288959092686557185"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "1096466731671973889"}, "tweet_id": "1289035225687822336"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1289160576027914240"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1289160597897019392"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "4901919879"}, "tweet_id": "1289161299230957568"}, {"license": "gnip", "citation_ids": [86279956], "author": {"tweeter_id": "1262777439605993472"}, "tweet_id": "1393487638234009603"}], "news": [{"title": "Global foundation awards Texas Biomed $1 million to conduct large-scale rodent testing of human monoclonal antibodies to combat SARS-CoV-2", "url": "https://sciencenewsnet.in/global-foundation-awards-texas-biomed-1-million-to-conduct-large-scale-rodent-testing-of-human-monoclonal-antibodies-to-combat-sars-cov-2/", "license": "public", "citation_ids": [86094936, 86279956], "posted_on": "2020-11-19T09:00:00+00:00", "summary": "Post Views: 1 San Antonio, Texas (Nov. 19, 2020) Texas Biomedical Research Institute (Texas Biomed) in San Antonio, Texas, was awarded $1 million from the Bill & Melinda Gates Foundation to test the efficacy of human monoclonal antibodies (MAbs) for\u2026", "author": {"name": "Sciencenewsnet.in", "url": "https://sciencenewsnet.in/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/005/084/normal/IN.PNG?1578485787"}}, {"title": "Global foundation awards Texas Biomed $1 million to test human MAbs to combat SARS-CoV-2 | Scienmag: Latest Science and Health News", "url": "https://scienmag.com/global-foundation-awards-texas-biomed-1-million-to-test-human-mabs-to-combat-sars-cov-2/", "license": "public", "citation_ids": [86094936, 86279956], "posted_on": "2020-11-19T14:49:30+00:00", "summary": "San Antonio, Texas (Nov. 19, 2020) \u2013 Texas Biomedical Research Institute (Texas Biomed) in San Antonio, Texas, was awarded $1 million from the Bill & Melinda Gates Foundation to test the efficacy of human monoclonal antibodies (MAbs) for the\u2026", "author": {"name": "ScienMag", "url": "http://scienmag.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/002/433/normal/Screen_Shot_2016-04-06_at_15.02.31.png?1459951595"}}, {"title": "Global foundation awards Texas Biomed $1 million to conduct large-scale rodent testing of human monoclonal antibodies to combat SARS-CoV-2", "url": "http://ct.moreover.com/?a=43596054389&p=1pl&v=1&x=zUq7zyAmUABq9bvJyjALyQ", "license": "public", "citation_ids": [86094936, 86279956], "posted_on": "2020-11-19T14:00:00+00:00", "summary": "Newswise \u2014 San Antonio, Texas (Nov. 19, 2020) \u2013 (Texas Biomed) in San Antonio, Texas, was awarded $1 million from the Bill & Melinda Gates Foundation to test the efficacy of human monoclonal antibodies (MAbs) for the treatment of SARS-CoV-2 infection.", "author": {"name": "Newswise", "url": "http://www.newswise.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/200/normal/image.png?1370251547"}}, {"title": "Global foundation awards Texas Biomed $1 million to test human MAbs to combat SARS-CoV-2", "url": "http://ct.moreover.com/?a=43596169138&p=1pl&v=1&x=Y5BwmOiCcQCNAYA6u_HOhw", "license": "public", "citation_ids": [86094936, 86279956], "posted_on": "2020-11-19T05:00:00+00:00", "summary": "San Antonio, Texas (Nov. 19, 2020) - Texas Biomedical Research Institute (Texas Biomed) in San Antonio, Texas, was awarded $1 million from the Bill & Melinda Gates Foundation to test the efficacy of human monoclonal antibodies (MAbs) for the\u2026", "author": {"name": "EurekAlert!", "url": "http://www.eurekalert.org/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/077/normal/EurekAlert_StackedLogo_Wht-RedBox.png?1573666452"}}, {"title": "Texas Biomed awarded $1 million to evaluate MAb therapeutics for COVID-19", "url": "http://ct.moreover.com/?a=43599698237&p=1pl&v=1&x=s-QGTlbBRUzrsIIfv_BAkw", "license": "public", "citation_ids": [86094936, 86279956], "posted_on": "2020-11-20T00:38:00+00:00", "summary": "Texas Biomedical Research Institute (Texas Biomed) in San Antonio, Texas, was awarded $1 million from the Bill & Melinda Gates Foundation to test the efficacy of human monoclonal antibodies (MAbs) for the treatment of SARS-CoV-2 infection.", "author": {"name": "The Medical News", "url": "http://www.news-medical.net/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/146/normal/image.png?1369927508"}}]}, "score": 82.35, "images": {"small": "https://badges.altmetric.com/?size=64&score=83&types=mttttttt", "medium": "https://badges.altmetric.com/?size=100&score=83&types=mttttttt", "large": "https://badges.altmetric.com/?size=180&score=83&types=mttttttt"}}